Impact of high-throughput screening in biomedical research.
about
Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor DiscoveryAt the Crossroads of Nanotoxicology in vitro: Past Achievements and Current ChallengesSystems pharmacology: network analysis to identify multiscale mechanisms of drug actionTrends in protein-based biosensor assemblies for drug screening and pharmaceutical kinetic studiesThe French National Compound Library: advances and future prospectsInhibition of microglia activation as a phenotypic assay in early drug discoveryBig data in chemical toxicity research: the use of high-throughput screening assays to identify potential toxicantsG-protein-coupled receptors targeting: the allosteric approachFloating Droplet Array: An Ultrahigh-Throughput Device for Droplet Trapping, Real-time Analysis and Recovery.A rapid and affordable screening platform for membrane protein trafficking.Engineering a Brain Cancer Chip for High-throughput Drug ScreeningExperimental and computational active site mapping as a starting point to fragment-based lead discoveryAntimalarial drug discovery - approaches and progress towards new medicines.DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learningNew target prediction and visualization tools incorporating open source molecular fingerprints for TB Mobile 2.0Review: basics of drug development in rheumatologyCurrent versus future reproduction and longevity: a re-evaluation of predictions and mechanismsIspE inhibitors identified by a combination of in silico and in vitro high-throughput screeningEnhancing hit identification in Mycobacterium tuberculosis drug discovery using validated dual-event Bayesian modelsHuman genetics in rheumatoid arthritis guides a high-throughput drug screen of the CD40 signaling pathwayIntegration of Microfractionation, qNMR and zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural productsTracking 20 years of compound-to-target output from literature and patentsIdentification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor libraryLooking back to the future: predicting in vivo efficacy of small molecules versus Mycobacterium tuberculosisEnd-to-end automated microfluidic platform for synthetic biology: from design to functional analysisTB Mobile: a mobile app for anti-tuberculosis molecules with known targetsBeyond small-molecule SAR: using the dopamine D3 receptor crystal structure to guide drug designEstimating Potency in High-Throughput Screening Experiments by Maximizing the Rate of Change in Weighted Shannon EntropyCurrent approaches for the discovery of drugs that deter substance and drug abuse.Natural products as sources of new drugs over the 30 years from 1981 to 2010Lead discovery and in silico 3D structure modeling of tumorigenic FAM72A (p17).Enhancing reproducibility in cancer drug screening: how do we move forward?Fusing dual-event data sets for Mycobacterium tuberculosis machine learning models and their evaluation.Challenges in secondary analysis of high throughput screening dataMining Natural-Products Screening Data for Target-Class Chemical Motifs.Are bigger data sets better for machine learning? Fusing single-point and dual-event dose response data for Mycobacterium tuberculosisQuantification of frequent-hitter behavior based on historical high-throughput screening data.Using the BioAssay Ontology for analyzing high-throughput screening data.Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.Whole genome sequencing identifies missense mutation in MTBP in Shar-Pei affected with Autoinflammatory Disease (SPAID)
P2860
Q26738763-42A59D57-92AE-4933-9E30-F217EB5E5B50Q26796677-BA339657-6B63-4CF3-A268-CF0323D74678Q26824166-B772CEAF-B812-4DF4-BA8A-FE82176062D6Q26859238-0490B016-325E-437D-AEDB-98D0902A141AQ26864840-43D5C402-CC5C-454B-B330-E23FA1B2062EQ26996061-8AD85E36-1EFE-48E3-8F05-79FA40054367Q27008504-D2507F52-83EF-49E7-BB94-2F281A23CF4DQ27023311-8689CCC5-763A-4B21-8F26-8F31061E343CQ27303576-E99227C5-FF85-4872-B457-D5D1C76D6A47Q27305088-9F262F13-F1EA-4F0D-837B-0A887592F38BQ27318558-EA51ECFD-12B9-4740-9270-50BB5E599606Q27676521-81B0E8E0-467F-4CFC-A9F5-45475074135AQ27693245-60E2C9DB-F4D5-42D0-B392-8CC3E99BD63FQ27902260-0ABEFD1E-B144-4C10-A85F-7027CD84EF22Q27902272-3BC72B1C-25BB-48F9-960A-7CFCF494D3C1Q28083593-38948980-590C-4F30-AA86-BBE044CC73FDQ28393133-ECE40EEC-7327-4C3C-B66E-0869969152DFQ28483059-60B4AC41-C54B-4206-A849-40CD6763D773Q28487748-6574E002-399E-447C-BD7D-8287BA20CDCEQ28488150-5DBBB233-8792-44D3-84C4-589F9A999A5FQ28488352-EFA72579-A1A3-4D56-8B94-835A1B3883C8Q28534695-776E9EA2-9274-4C4E-9340-0D4005FD2CF7Q28534763-030F4DC6-23A4-445B-94AA-02915D68A7C3Q28538272-65DEA376-1C3D-42FA-B634-4A5AB98689EDQ28601604-DB71295E-2C2F-434F-A29C-5A8DABC504E6Q28709353-CB36837E-1CB6-468F-B1DE-76BFBFC5F8AFQ28828620-49982970-4E07-4B90-93F5-EC1187047154Q28830270-6D64A9DF-A3F6-42E1-A829-E912D128F8B0Q28973615-620F3F42-136A-4B46-995A-42AA5A7A83D6Q29616640-2E8CEC43-DC82-4675-B8BA-82E198716F26Q30366970-9280AA19-61D2-476F-93E5-A4D031235946Q30405622-B63F5386-F3AB-4B1E-BDF8-64CBC49614BAQ30681280-B668D406-5648-459C-B471-03F19DE00002Q30705788-3B812127-0DA4-4237-8F49-79C396ED07EDQ30755326-A6D0171F-2C8E-43C4-8238-4ABD07C2A853Q30833510-8D5F8AB1-FF06-4171-A670-8E6E9CD2A398Q30839726-712AC646-4FB8-48CF-B472-A7AD428908CEQ30878704-A03D8203-BE43-4FAA-A045-78D83921EBD6Q31139520-1C86D7CD-63B8-48DA-8FAB-40DA542FE875Q33640755-6887887B-0161-40C5-8A95-199CB14070BC
P2860
Impact of high-throughput screening in biomedical research.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impact of high-throughput screening in biomedical research.
@en
Impact of high-throughput screening in biomedical research.
@nl
type
label
Impact of high-throughput screening in biomedical research.
@en
Impact of high-throughput screening in biomedical research.
@nl
prefLabel
Impact of high-throughput screening in biomedical research.
@en
Impact of high-throughput screening in biomedical research.
@nl
P2093
P2860
P356
P1476
Impact of high-throughput screening in biomedical research.
@en
P2093
Darren V S Green
David J Burns
Dejan Bojanic
G Sitta Sittampalam
Jeff W Paslay
Martyn N Banks
Ricardo Macarron
Robert P Hertzberg
Tina Garyantes
Ulrich Schopfer
P2860
P2888
P304
P356
10.1038/NRD3368
P577
2011-03-01T00:00:00Z
P5875
P6179
1041527430